Literature DB >> 22356322

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Ann G Zauber1, Sidney J Winawer, Michael J O'Brien, Iris Lansdorp-Vogelaar, Marjolein van Ballegooijen, Benjamin F Hankey, Weiji Shi, John H Bond, Melvin Schapiro, Joel F Panish, Edward T Stewart, Jerome D Waye.   

Abstract

BACKGROUND: In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer.
METHODS: We included in this analysis all patients prospectively referred for initial colonoscopy (between 1980 and 1990) at NPS clinical centers who had polyps (adenomas and nonadenomas). The National Death Index was used to identify deaths and to determine the cause of death; follow-up time was as long as 23 years. Mortality from colorectal cancer among patients with adenomas removed was compared with the expected incidence-based mortality from colorectal cancer in the general population, as estimated from the Surveillance Epidemiology and End Results (SEER) Program, and with the observed mortality from colorectal cancer among patients with nonadenomatous polyps (internal control group).
RESULTS: Among 2602 patients who had adenomas removed during participation in the study, after a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal cancer. Given an estimated 25.4 expected deaths from colorectal cancer in the general population, the standardized incidence-based mortality ratio was 0.47 (95% confidence interval [CI], 0.26 to 0.80) with colonoscopic polypectomy, suggesting a 53% reduction in mortality. Mortality from colorectal cancer was similar among patients with adenomas and those with nonadenomatous polyps during the first 10 years after polypectomy (relative risk, 1.2; 95% CI, 0.1 to 10.6).
CONCLUSIONS: These findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer. (Funded by the National Cancer Institute and others.).

Entities:  

Mesh:

Year:  2012        PMID: 22356322      PMCID: PMC3322371          DOI: 10.1056/NEJMoa1100370

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  49 in total

1.  Colonoscopy vs sigmoidoscopy screening: getting it right.

Authors:  Alfred I Neugut; Benjamin Lebwohl
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

2.  Editorial: colonoscopy and colorectal cancer mortality: strong beliefs or strong facts?

Authors:  Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2010-07       Impact factor: 10.864

3.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

Authors:  Peter M Rothwell; Michelle Wilson; Carl-Eric Elwin; Bo Norrving; Ale Algra; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-10-21       Impact factor: 79.321

4.  Equipoise and the dilemma of randomized clinical trials.

Authors:  Franklin G Miller; Steven Joffe
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

5.  Protection from colorectal cancer after colonoscopy: a population-based, case-control study.

Authors:  Hermann Brenner; Jenny Chang-Claude; Christoph M Seiler; Alexander Rickert; Michael Hoffmeister
Journal:  Ann Intern Med       Date:  2011-01-04       Impact factor: 25.391

6.  Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.

Authors:  D A Lieberman; D G Weiss; J H Bond; D J Ahnen; H Garewal; G Chejfec
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

7.  Studying cancer in minorities: a look at the numbers.

Authors:  Sara H Olson; Tracy M Layne; Jennifer A Simon; Emmy Ludwig; Eileen O'Reilly; Peter J Allen; Robert C Kurtz
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

8.  The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer.

Authors:  Harminder Singh; Zoann Nugent; Alain A Demers; Erich V Kliewer; Salaheddin M Mahmud; Charles N Bernstein
Journal:  Gastroenterology       Date:  2010-06-20       Impact factor: 22.682

9.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

Authors:  Peter M Rothwell; F Gerald R Fowkes; Jill F F Belch; Hisao Ogawa; Charles P Warlow; Tom W Meade
Journal:  Lancet       Date:  2010-12-06       Impact factor: 79.321

10.  Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.

Authors:  J L Jouve; L Remontet; V Dancourt; C Lejeune; A M Benhamiche; J Faivre; J Esteve
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

View more
  886 in total

1.  Gastrointestinal cancer: Should colonoscopy be a primary test in CRC screening?

Authors:  Evelien Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-04-10       Impact factor: 66.675

2.  Linked color imaging improves the visibility of various featured colorectal polyps in an endoscopist's visibility and color difference value.

Authors:  Naohisa Yoshida; Yuji Naito; Ritsu Yasuda; Takaaki Murakami; Ryohei Hirose; Kiyoshi Ogiso; Yutaka Inada; Osamu Dohi; Kazuhiro Kamada; Kazuhiko Uchiyama; Osamu Handa; Hideyuki Konishi; Rafiz Abdul Rani; Mitsuo Kishimoto; Eiichi Konishi; Yoshito Itoh
Journal:  Int J Colorectal Dis       Date:  2017-07-19       Impact factor: 2.571

3.  Does Provider Gender Affect the Quality of Primary Care?

Authors:  Jeffrey L Jackson; Amy Farkas; Cecilia Scholcoff
Journal:  J Gen Intern Med       Date:  2020-04-06       Impact factor: 5.128

4.  Does training and experience influence the accuracy of computed tomography colonography interpretation?

Authors:  Greg Rosenfeld; Yi Tzu Nancy Fu; Brendan Quiney; Hong Qian; Darin Krygier; Jacquie Brown; Patrick Vos; Pari Tiwari; Jennifer Telford; Brian Bressler; Robert Enns
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 5.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

6.  Patients with Non-Hodgkin's Lymphoma Are at Risk of Adenomatous Colon Polyps.

Authors:  Hamzah Abu-Sbeih; Ellie Chen; Osman Ahmed; Niharika Mallepally; Phillip Lum; Wei Qiao; Hun Ju Lee; Robert Bresalier; Lan Sun Wang; Brian Weston; Gottumukkala S Raju; Yinghong Wang
Journal:  Dig Dis Sci       Date:  2019-05-03       Impact factor: 3.199

7.  Ethnic disparities in the risk of colorectal adenomas associated with aspirin and statin use: a retrospective multiethnic study.

Authors:  Ashley H Davis-Yadley; Seth Lipka; Huafeng Shen; Hirak Shah; Supreeya Swarup; Alex Barnowsky; Jeff Silpe; Josh Mosdale; Qinshi Pan; Svetlana Fridlyand; Suhas Sreeharshan; Albin Abraham; Prakash Viswanathan; Bhuma Krishnamachari
Journal:  J Gastrointest Oncol       Date:  2014-04

8.  Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?

Authors:  Electra D Paskett; Fadlo R Khuri
Journal:  Cancer       Date:  2015-03-12       Impact factor: 6.860

9.  Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals.

Authors:  Uri Ladabaum; Ajitha Mannalithara; Lina Jandorf; Steven H Itzkowitz
Journal:  Cancer       Date:  2014-12-09       Impact factor: 6.860

10.  Public health and cooperative group partnership: a colorectal cancer intervention.

Authors:  Sherri G Homan; Bob R Steward; Jane M Armer
Journal:  Semin Oncol Nurs       Date:  2013-12-19       Impact factor: 2.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.